[Fluconazole prophylaxis for fungal peritonitis in peritoneal dialysis].
Morey
A
A
Lima
C
C
Matas
B
B
Munar
M A
MA
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000453:epidemiology; D003928:Diabetic Nephropathies / Q000150:complications / Q000628:therapy; D004198:Disease Susceptibility; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D015725:Fluconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D013030:Spain / Q000453:epidemiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D015725:Fluconazole